Regional Citrate Anticoagulation for High Volume Continuous Venovenous Hemodialysis in Surgical Patients With High Bleeding Risk

Therapeutic Apheresis and Dialysis

Volumn 17, Issue 2, 2013, Pages 202-212

  Kalb, Robert ^a   Kram, Rainer ^a   Morgera, Stanislao ^b   Slowinski, Torsten ^b   Kindgen Milles, Detlef ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute kidney injury; Continuous renal replacement therapy; Dialysis dose; Hemodialysis; Regional citrate anticoagulation

Indexed keywords

CITRIC ACID; DIALYSIS FLUID;

ACID BASE BALANCE; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONTINUOUS HEMODIALYSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPOCALCEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL PATIENT; UNSPECIFIED SIDE EFFECT;

ACID-BASE EQUILIBRIUM; ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CITRIC ACID; FEMALE; HEMORRHAGE; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; TIME FACTORS;

EID: 84875813993     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2012.01101.x     Document Type: Article

References (31)

1. Prescott GJ, Metcalfe W, Baharani J etal. A prospective national study of acute renal failure treated with RRT: incidence, aetiology and outcomes. Nephrol Dial Transplant 2007;22:2513-9.
2. Kellum JA, Bellomo R, Ronco C. Definition and classification of acute kidney injury. Nephron Clin Pract 2008;109:c182-c187.
3. Ronco C, Cruz D, Bellomo R. Continuous renal replacement in critical illness. Contrib Nephrol 2007;156:309-19.
4. Rabindranath K, Adams J, MacLeod AM, Muirhead N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev 2007;18:CD003773.
5. Brophy PD, Somers MJ, Baum MA etal. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant 2005;20:1416-21.
6. Uchino S, Bellomo R, Morimatsu H etal. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 2007;33:1563-70.
7. Oudemans-van Straaten HM, Wester JP, de Pont AC, Schetz MR. Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based? Intensive Care Med 2006;32:188-202.
8. Oudemans-van Straaten HM. Citrate anticoagulation for continuous renal replacement therapy in the critically ill. Blood Purif 2010;29:191-6.
9. Kutsogiannis DJ, Gibney RT, Stollery D, Gao J. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005;67:2361-7.
10. Betjes MG, van Oosterom D, van Agteren M, van de Wetering J. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding. J Nephrol 2007;20:602-8.
11. Bihorac A, Ross EA. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition. Am J Kidney Dis 2005;46:908-18.
12. Morgera S, Schneider M, Slowinski T etal. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med 2009;37:2018-24.
13. Kellum JA, Lameire N, Aspelin P etal. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:1-138.
14. Morgera S, Scholle C, Voss G etal. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience. Nephron Clin Pract 2004;97:c131-c136.
15. Durao MS, Monte JC, Batista MC etal. The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury. Crit Care Med 2008;36:3024-9.
16. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004;30:260-5.
17. Hetzel GR, Schmitz M, Wissing H etal. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 2011;26:232-9.
18. Zhang Z, Hongying N. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med 2012;38:20-8.
19. Mariano F, Tedeschi L, Morselli M, Stella M, Triolo G. Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients. Intensive Care Med 2010;36:1735-43.
20. James MF, Roche AM. Dose-response relationship between plasma ionized calcium concentration and thrombelastography. J Cardiothorac Vasc Anesth 2004;18:581-6.
21. Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C. Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Med 2002;28:1419-25.
22. Naka T, Egi M, Bellomo R etal. Commercial low-citrate anticoagulation haemofiltration in high risk patients with frequent filter clotting. Anaesth Intensive Care 2005;33:601-8.
23. Ronco C, Bellomo R, Homel P etal. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356:26-30.
24. Bellomo R, Cass A, Cole L etal. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009;361:1627-38.
25. Vijayan A, Palevsky PM. Dosing of renal replacement therapy in acute kidney injury. Am J Kidney Dis 2012;59:569-76.
26. Vesconi S, Cruz DN, Fumagalli R etal. Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care 2009;13:R57.
27. Phu NH, Hien TT, Mai NT etal. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 2002;347:895-902.
28. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002;346:305-10.
29. Kron J, Kron S, Wenkel R etal. Extended daily on-line high-volume haemodiafiltration in septic multiple organ failure: a well-tolerated and feasible procedure. Nephrol Dial Transplant 2012;27:146-52.
30. Kindgen-Milles D, Amman J, Kleinekofort W, Morgera S. Treatment of metabolic alkalosis during continuous renal replacement therapy with regional citrate anticoagulation. Int J Artif Organs 2008;31:363-6.
31. Morgera S, Haase M, Ruckert M etal. Regional citrate anticoagulation in continuous hemodialysis-acid-base and electrolyte balance at an increased dose of dialysis. Nephron Clin Pract 2005;101:c211-9.